Composition and method

Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31365

Patent

active

039652750

ABSTRACT:
A process, and the composition used therein, for estrogenic therapy which comprises administering daily to the patient from about 0.2 to 2000 milligrams of a compound having the formula: ##EQU1## wherein R is selected from the group consisting of hydrogen, lower alkyl and a lower saturated acyclic acyl; Z is selected from the group consisting of >CH.sub.2, >CHOH and >C=O; and A is selected from the group consisting of --CH.sub.2 --CH.sub.2 -- and --CH=CH--.

REFERENCES:
patent: 3239341 (1966-03-01), Hodge et al.
patent: 3239342 (1966-03-01), Hodge et al.
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3239347 (1966-03-01), Hodge et al.
Goodman et al., The Pharmaceutical Basis of Therapeutics, 3rd Ed., pp. 1382, 1383, 1541-1544, 1548-1552, The MacMillan Co. N.Y. (1965).
Chemical Abstracts vol. 72: 53749u; vol. 72: 41764g; vol. 69: 1932s; vol. 69: items 1933t, 42911c, 42912d, 86648b, 86649c, 86650w, 86651x, 86652y, 86653z, 86654a, 86655b, 96505s and 106281g.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2288921

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.